» Articles » PMID: 19286566

The Long Pentraxin PTX3 is Crucial for Tissue Inflammation After Intestinal Ischemia and Reperfusion in Mice

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2009 Mar 17
PMID 19286566
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The pentraxin superfamily is a group of evolutionarily conserved proteins that play important roles in the immune system. The long pentraxin PTX3 protein was originally described as able to be induced by pro-inflammatory stimuli in a variety of cell types. In this study, we evaluated the phenotype of Ptx3(-/-) mice subjected to ischemia followed by reperfusion of the superior mesenteric artery. In reperfused wild-type mice, there was significant local and remote injury as demonstrated by increases in vascular permeability, neutrophil influx, nuclear factor-kappaB activation, and production of CXCL1 and tumor necrosis factor-alpha. PTX3 levels were elevated in both serum and intestine after reperfusion. In Ptx3(-/-) mice, local and remote tissue injury was inhibited, and there were decreased nuclear factor-kappaB translocation and cytokine production. Intestinal architecture was preserved, and there were decreased neutrophil influx and significant prevention of lethality in Ptx3(-/-) mice as well. PTX3 given intravenously before reperfusion reversed the protection observed in Ptx3(-/-) mice in a dose-dependent manner, and PTX3 administration significantly worsened tissue injury and lethality in wild-type mice. In conclusion, our studies demonstrate a major role for PTX3 in determining acute reperfusion-associated inflammation, tissue injury, and lethality and suggest the soluble form of this molecule is active in this system. Therapeutic blockade of PTX3 action may be useful in the control of the injuries associated with severe ischemia and reperfusion syndromes.

Citing Articles

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats.

Laszlo S, Hutka B, Toth A, Hegyes T, Demeter Z, Haghighi A Front Pharmacol. 2024; 15:1468579.

PMID: 39584137 PMC: 11582421. DOI: 10.3389/fphar.2024.1468579.


Modulation of diabetes-related retinal pathophysiology by PTX3.

Pathak V, Bertelli P, Pedrini E, Harkin K, Peixoto E, Allen L Proc Natl Acad Sci U S A. 2024; 121(41):e2320034121.

PMID: 39348530 PMC: 11474045. DOI: 10.1073/pnas.2320034121.


The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?.

Panebianco M, Ciccarese C, Strusi A, Beccia V, Carbone C, Agostini A Cancers (Basel). 2024; 16(3).

PMID: 38339243 PMC: 10854780. DOI: 10.3390/cancers16030490.


Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives.

Miceli V, Bulati M, Gallo A, Iannolo G, Busa R, Conaldi P Biomedicines. 2023; 11(3).

PMID: 36979668 PMC: 10045387. DOI: 10.3390/biomedicines11030689.


The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure.

Szczurek-Wasilewicz W, Skrzypek M, Romuk E, Gasior M, Szygula-Jurkiewicz B J Clin Med. 2022; 11(9).

PMID: 35566693 PMC: 9099900. DOI: 10.3390/jcm11092567.


References
1.
Souza D, Cassali G, Poole S, Teixeira M . Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol. 2001; 134(5):985-94. PMC: 1573029. DOI: 10.1038/sj.bjp.0704336. View

2.
Inoue K, Sugiyama A, Reid P, Ito Y, Miyauchi K, Mukai S . Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2006; 27(1):161-7. DOI: 10.1161/01.ATV.0000252126.48375.d5. View

3.
Soares A, Souza D, Pinho V, Vieira A, Nicoli J, Cunha F . Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice. Microbes Infect. 2006; 8(5):1321-9. DOI: 10.1016/j.micinf.2005.12.017. View

4.
Sousa L, Silva B, Brasil B, Nogueira S, Ferreira P, Kroon E . Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway. Biochem Biophys Res Commun. 2005; 337(4):1065-71. DOI: 10.1016/j.bbrc.2005.09.154. View

5.
Cugini D, Azzollini N, Gagliardini E, Cassis P, Bertini R, Colotta F . Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int. 2005; 67(5):1753-61. DOI: 10.1111/j.1523-1755.2005.00272.x. View